TMCnet News
Research and Markets: Dilated Cardiomyopathy Therapeutics Market - Global Pipeline Analysis 2014 - 2020Research and Markets (http://www.researchandmarkets.com/research/dw6f9d/dilated) has announced the addition of the "Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. The global dilated cardiomyopathy therapeutics market is studied in this report from three perspectives: by drug class, by pipelined products and by geography. Dilated cardiomyopathy therapeutics market by drug class encompasses aldosterone antagonists, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs) and beta-blockers. A detailed market analysis and forecast for each of these segments have been provided in this study, in terms of market revenue (USD million) for the period 2012 to 2020. The report also provides the compounded annual growth rate for each of these segments for the forecast period from 2014 to 2020,considering 2012 and 2013 as base years. The market overview section of the report demonstrates the major factors determining the market dynamics such as drivers, restraints and opportunities that influence the current as well as future status of this industry. The market overview section of the report also includes qualitative and quantitative analysis of the competitive landscape covering market share analysis by key players. The study also suggests a list of recommendations which would be useful for existing and future market players in decision making for business growth. Pipeline analysis (Phase I and Phase II) for dilated cardiomyopathy therapeutics market has also been covered in the report. The report concludes with the company profiles section, which illustrates key information about the major players in this market such as company overview, financial overview, product portfolio, business strategies and recent developments. The global dilated cardiomyopathy therapeutics market is segmented into the following categories: Dilated cardiomyopathy therapeutics market, by drug class - Aldosterone antagonists - Angiotensin-converting enzyme (ACE) inhibitors - Angiotensin II receptor blockers (ARBs) - Beta-blockers Dilated cardiomyopathy therapeutics market, by pipeline drugs - ARRY-797 - MYDICAR - OR-1 - CAP-1002 Companies Mentioned - Array BioPharma, Inc. - AstraZeneca plc - Celladon Corporation - GlaxoSmithKline plc - Janssen Pharmaceuticals, Inc. - Merck & Co., Inc. - Novartis International AG - Pfizer, Inc. - Sanofi S.A. - Teva Pharmaceutical Industries Ltd. - Vericel Corporation For more information visit http://www.researchandmarkets.com/research/dw6f9d/dilated
|
